← back to search

Bert Schepens

Vlaams Instituut voor Biotechnologie · BE
Area of research
Epidemiology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Influenza Virus Research Studies, Monoclonal and Polyclonal Antibodies Research, Respiratory viral infections research, and Viral gastroenteritis research and epidemiology.
h-index
38
citations
4,883
works
88
NIH funding
primary concept
Biology
email

Recent publications

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base
Nature Communications 2025cited by 8position: contributordoi
Development of a General Purpose Targeted LC-MS Method for Accurate Quantification of the SARS-CoV-2 Spike Protein Expression
2025cited by 0position: contributordoi
Yeast-based production platform for potent and stable heavy chain-only antibodies
2024cited by 0position: contributordoi
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery.
2023cited by 6position: contributordoi
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
2023cited by 4position: contributordoi
An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
Science Translational Medicine 2021cited by 67position: firstdoi
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.
2021cited by 59position: contributordoi
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Nature Communications 2020cited by 292position: middledoi
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein.
2020cited by 8position: contributordoi
Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody
Journal of Virology 2015cited by 67position: middledoi
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
EMBO Molecular Medicine 2014cited by 57position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2020–2025)Xavier Saelens · Utrecht University5 papers (2014–2025) · 3 papers (2023–2025) · 3 papers (2023–2025)Rana Abdelnabi · Omdurman Islamic University2 papers (2023–2025)Koen Sedeyn · Ghent University2 papers (2023–2025)Nincy Debeuf · Ghent University Hospital2 papers (2023–2025) · 2 papers (2023–2025)Sophie Shoemaker · Johns Hopkins Medicine2 papers (2023–2025)Wim Nerinckx · Ghent University2 papers (2023–2023)Sieglinde De Cae · Ghent University2 papers (2023–2025)Chiara Lonigro · Ghent University2 papers (2023–2025) · 2 papers (2023–2025)Nico Callewaert · VIB-UGent Center for Inflammation Research2 papers (2023–2025)Kenny Roose · Vlaams Instituut voor Biotechnologie2 papers (2014–2015) · 2 papers (2014–2015)Joanne M. Langley · Alberta Children's Hospital1 papers (2020–2020)Jihye Lee · Pohang University of Science and Technology1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2015–2015)